Mucor or mucormycosis

Mucor or Mucormycosis

Mucor or mucormycosis is a fungal infection caused by the Mucoromycotina fungus group. Fungi are associated with dead and decaying organic matter. Fungi can also be found in soil. Mucormycosis is not communicable and is connected with patients who have a weaker immune system. Skin traumas such as burns, organ transplants, uncontrolled diabetes conditions, tumor and malignant growths, and a low number of White Blood Cells can all lead to lowered immunity (WBCs). Mucor infection occurs when a patient inhales fungal spores from his or her surroundings, and the spores induce infection. Also, the patient may come into contact with the fungus through the skin. The fungus gains entry into the body if the skin has cuts, burns, or is traumatized in any other way. Once in the body, the fungi multiply and colonize various body sites without causing any disease. The Aspergillus species of the fungi progresses to pneumonia when the body tissues get damaged, and the body defense system is weakened (Benedict et al., 2017). The patient can be treated by use of antifungal medications to limit the spread of the fungal infections and treat any other opportunistic infections. Surgery can be conducted to remove the infected body tissues.

Partial O2 Pressure and Partial Carbon Dioxide Pressure

Partial O2 pressure is below the average 72mmHg, and Partial carbon dioxide gas pressure is below the normal 45 mmHg. The low levels of oxygen and carbon dioxide exhaled or in the blood is due to malfunctioning of some regions of the lungs. The treatment for the patient will include the use of anti-inflammatory immune complications, surgery to remove affected tissue, and quick attenuation of immunosuppressive agents (Trief et al., 2015). The medications to be used by the patient will include Amphotericin B for severe cases, triazoles for people with mild conditions, and fluconazole for moderate infection.

References

Benedict, K., Richardson, M., Vallabhaneni, S., Jackson, B. R., & Chiller, T. (2017). Emerging issues, challenges, and changing epidemiology of fungal disease outbreaks. The Lancet Infectious Diseases.

Trief, D., Gray, S. T., Jakobiec, F. A., Durand, M. L., Fay, A., Freitag, S. K., & Sadow, P. (2015). Invasive fungal disease of the sinus and orbit: a comparison between mucormycosis and Aspergillus. British Journal of Ophthalmology, bjophthalmol-2015.